Skip to main content

Table 3 Multivariable analysis for DFS in the validation cohort

From: Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment

Variables HR 95% CI p value
Age 0.981 0.951–1.012 0.232
cTNM stage (III vs II)    
IIIa-b vs II 1.092 0.510–2.339 0.820
IIIc vs II 1.884 0.752–4.717 0.176
pCR (Yes vs No) 1.022 0.456–2.295 0.957
IMNI (Yes vs No) 1.427 0.702–2.904 0.326
HR (HR + vs HR −) 1.297 0.553–3.041 0.550
HER2 (HER2 + vs HER2 −) 1.085 0.495–2.380 0.839
Radiomics score 1.002 1.000–1.005 0.042
  1. HR hormonal receptor, HER2 human epidermal growth factor receptor 2, IMNI internal mammary node irradiation